Induztr
Engineering Digest Document Viewer Related Models

Evaluation of Chromatographic Parameters Influencing GLP-1 Peptide Impurity Profiling

Technical Reference Summary

Covered Models & Document Scope

Application note covering reversed-phase LC method development for GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) and their related impurities using the Agilent Altura Peptide Plus column (part number 227215-903) with the Agilent 1260 Infinity III Prime Bio LC system and Agilent InfinityLab Pro iQ Plus; no instrument model variants or ordering codes are defined.

Technical Data

Parameter Value Condition
Analytical column Agilent Altura Peptide Plus p.2 ↗ part number 227215-903
Column particle size 2.7 µm p.9 ↗ Altura Peptide Plus
LC system Agilent 1260 Infinity III Prime Bio LC p.1 ↗
Detector Agilent InfinityLab Pro iQ Plus p.1 ↗
Ion source Agilent Jet Stream ESI source p.3 ↗
Sheath gas flow 12 L/min p.3 ↗
Gas temperature 270 °C p.3 ↗
Injection volume 1.0 µL p.3 ↗
DAD flow cell Agilent InfinityLab Bio-inert Max-Light p.3 ↗
Mobile-phase additive (TFA) concentration 0.05 % p.5 ↗ best overall chromatographic performance
Column compartment temperature 60 °C p.10 ↗ semaglutide and liraglutide
Sample loading amount 1.2 µg p.9 ↗ Altura Peptide Plus, 2.7 µm
Mobile-phase additive (FA) concentration 0.4 % p.6 ↗ tirzepatide

Operating Limits

  • Column compartment temperature evaluated: 60–70 °C p.10 ↗
  • TFA concentration evaluated: 0.05–1% p.5 ↗
  • FA concentration evaluated: 0.4% p.6 ↗